Fierce Healthcare May 15, 2024
To boost domestic medical supply manufacturing, the Biden administration is hiking up tariffs on syringes, needles, medical and surgical gloves and personal protective equipment from China.
The tariffs are designed to combat artificially low-priced exports coming in from China, the federal government said in a fact sheet released yesterday.
“American businesses are now struggling to compete with underpriced Chinese-made supplies dumped on the market, sometimes of such poor quality that they may raise safety concerns for health care workers and patients,” the White House said.
President Biden directed his Trade Representative to increase tariffs under Section 301 of the Trade Act of 1974 on $18 billion of imports from China.
In 2024, the tariff rates on syringes and needles will...
Today's Sponsors
Today's Sponsor